Skip to main content
Top
Published in: Journal of Neurology 8/2022

Open Access 21-03-2022 | Dementia | Original Communication

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls

Authors: Carl Counsell, Cinzia Giuntoli, Qaisar Imran Khan, Jodi Maple-Grødem, Angus D. Macleod

Published in: Journal of Neurology | Issue 8/2022

Login to get access

Abstract

Background

There are few long-term data on the incidence, baseline predictors, and outcomes of dementia in Parkinson’s disease (PD) from prospective community-based incident cohorts.

Methods

The PINE study prospectively identified all incident PD patients in Aberdeen along with age–sex-matched, community-based controls who consented to standardized annual life-long follow-up. Each year, a clinical expert reviewed the diagnosis of PD and the presence of dementia according to DSM-IV-based criteria. Age–sex stratified incidence rates for dementia in PD and controls were calculated and compared with hazard ratios (HR) adjusted for age, sex, education, and socioeconomic status. Cox proportional-hazard modelling was used to assess baseline predictors for PD dementia and the influence of dementia on survival and institutionalization.

Results

201 patients (mean age 72.6yrs) and 260 controls (mean age 75.4yrs) were followed for median 9.5 years. The incidence of dementia was 7.4 (PD) versus 2.1 (controls) per 100 person-years (adjusted HR 6.0, 95%CI 4.1–8.7), with a sixfold increase from under 60 to over 80 years in PD but no sex difference. Independent baseline predictors of PD dementia were older age at diagnosis, self-reported cognitive symptoms, dream enactment, lower MMSE scores, worse motor UPDRS scores, and the ApoE genotype. PD dementia increased the rates of subsequent death and institutionalization (32.0 and 26.9 per 100 person-years, respectively).

Conclusion

The incidence of dementia in PD is high, increases markedly with age, is increased in those with baseline subjective cognitive symptoms as well as other established risk factors, and is associated with high rates of death and institutionalization.
Appendix
Available only for authorised users
Literature
14.
go back to reference Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR (2017) Prediction of cognition in Parkinson’s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol 16:620–629. https://doi.org/10.1016/S1474-4422(17)30122-9CrossRefPubMedPubMedCentral Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR (2017) Prediction of cognition in Parkinson’s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol 16:620–629. https://​doi.​org/​10.​1016/​S1474-4422(17)30122-9CrossRefPubMedPubMedCentral
22.
go back to reference Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. https://doi.org/10.1002/mds.21507CrossRefPubMed Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. https://​doi.​org/​10.​1002/​mds.​21507CrossRefPubMed
24.
go back to reference McLoone P (2004) Carstairs scores for Scottish postcode sectors from the 2001 Census. MRC Social and Public Health Sciences Unit, Glasgow McLoone P (2004) Carstairs scores for Scottish postcode sectors from the 2001 Census. MRC Social and Public Health Sciences Unit, Glasgow
29.
go back to reference Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P, Members of the MDS Rating Scales Review Committee (2018) Global scales for cognitive screening in Parkinson’s disease: critique and recommendations. Mov Disord 33:208–218. https://doi.org/10.1002/mds.27233CrossRefPubMed Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P, Members of the MDS Rating Scales Review Committee (2018) Global scales for cognitive screening in Parkinson’s disease: critique and recommendations. Mov Disord 33:208–218. https://​doi.​org/​10.​1002/​mds.​27233CrossRefPubMed
Metadata
Title
The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
Authors
Carl Counsell
Cinzia Giuntoli
Qaisar Imran Khan
Jodi Maple-Grødem
Angus D. Macleod
Publication date
21-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2022
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-022-11058-2

Other articles of this Issue 8/2022

Journal of Neurology 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine